Compounds > 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
Page last updated: 2024-09-02

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Graft vs Host Disease

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jansen, J; Zwaan, FE1

Reviews

1 review(s) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Graft vs Host Disease

ArticleYear
Bone marrow transplantation in acute nonlymphoblastic leukemia.
    Seminars in hematology, 1984, Volume: 21, Issue:1

    Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia; Methotrexate; Piperazines; Prognosis; Recurrence; Whole-Body Irradiation

1984